Back to Interventions

Substance / Medication

Calcitonin

SNOMED 63730009 UMLS C0006668

Overview

Active Ingredient

calcitonin

RxNorm CUI

1311287

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Osteitis deformans

Menopausal osteoporosis

Osteogenesis imperfecta

Postmenopausal osteoporosis

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

LOINC 15035-9

name_match

Clinical Trials

3 trials linked to this intervention

3

Total Trials

1

Recruiting

2

With Results

Recent Trials

Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity

NCT03935984Phase 4Recruiting37 enrolled

The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries

NCT03812991Phase 4Completed21 enrolled

Hypothyroidism Treated With Calcitonin

NCT03342001Phase 4Completed11 enrolled

View all 3 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Calcitonin Gene-Related Peptide (CGRP) Levels of Children and Adolescents With Migraine: A Systematic Review and Meta-Analysis of Observational Studies.

Zhu Guoliang, Yan Guifang, Luo Ying et al. · Eur J Pain · 2026

PMID: 41312882Meta-Analysis

Unveiling the efficacy and safety of Erenumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, in patients with chronic and episodic migraine: a GRADE-assessed systematic review and meta-analysis of randomized clinical trials with subgroup analysis.

Haseeb Mohamed E, Mohammed Hazem E, Yaser Hatem et al. · Head Face Med · 2025

PMID: 40134001Meta-AnalysisFull text (PMC)

Effects of calcitonin on lumbar spinal stenosis.

Lu Guang-Qi, Zhuang Ming-Hui, Liu Yi-Ying et al. · Arch Orthop Trauma Surg · 2024

PMID: 38436716Meta-Analysis

Nonspecific oral medications versus anti-calcitonin gene-related peptide monoclonal antibodies for migraine: A systematic review and meta-analysis of randomized controlled trials.

Robblee Jennifer, Hakim Sameh M, Reynolds John M et al. · Headache · 2024

PMID: 38634515Meta-Analysis

Safety and Efficacy of Calcitonin Gene-related Peptide Receptor Antagonists and Selective Serotonin Receptor Agonist in the Management of Migraine: A Systematic Review and Meta-analysis.

Singh Pooja, Ponnada Rakesh Kumar, Sharma Ruchika et al. · CNS Neurol Disord Drug Targets · 2024

PMID: 38847252Meta-Analysis

Assessing the occurrence of hypertension in patients receiving calcitonin gene-related peptide monoclonal antibodies for episodic and chronic migraine: a systematic review and meta-analysis.

Di Meiqi, Hu Lingling, Gui Shuhua et al. · J Oral Facial Pain Headache · 2024

PMID: 39800953Meta-AnalysisFull text (PMC)

Prevalence and significance of indeterminate calcitonin values in patients with thyroid nodules: A systematic review and meta-analysis.

Piticchio Tommaso, Frasca Francesco, Trimboli Pierpaolo · Rev Endocr Metab Disord · 2023

PMID: 37254023Meta-AnalysisFull text (PMC)

Calcitonin in the Treatment of Phantom Limb Pain: A Systematic Review.

Neumüller Johannes, Lang-Illievich Kordula, Brenna Connor T A et al. · CNS Drugs · 2023

PMID: 37261670Meta-AnalysisFull text (PMC)

Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies.

Ferreira Vinicius L, Mainka Felipe F, Wiens Astrid et al. · Clin Drug Investig · 2023

PMID: 37665501Meta-Analysis

Head-to-head comparison of FNA cytology vs. calcitonin measurement in FNA washout fluids (FNA-CT) to diagnose medullary thyroid carcinoma. A systematic review and meta-analysis.

Trimboli Pierpaolo, Giannelli Jacopo, Marques Bernardo et al. · Endocrine · 2022

PMID: 34606057Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Calcitonin (substance)
SNOMED CT: 63730009
UMLS CUI: C0006668
RxNorm CUI: 1311287

Clinical Data

This intervention maps to 6 entities in the Ltrl knowledge graph.

5

Conditions

1

Biomarkers

0

Specialists

0

Symptoms

3

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.